Company page

Apimeds Pharmaceuticals Us, Inc.

Apimeds Pharmaceuticals Us, Inc. (ticker: APUS) is a public company operating in the American market. With a market capitalization of approximately $98.6 million, the company focuses on developing pharmaceutical products. Investors can find relevant information about its operations and performance on its dedicated public company page.